Pages

Thursday, March 20, 2014

Inhibition of CDK4 might promote lymphoma development, progression

Anticancer agents that inhibit tumor growth by targeting a cell-cycle regulatory protein called CDK4 might actually promote the development and progression of certain B-cell lymphomas.

http://ift.tt/1eWYdRe

No comments:

Post a Comment